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Abstract 
 
Objective(s) 
Although photodynamic therapy is considered as a noninvasive method, most photosensitizers are susceptible 
to ultrasound. Therefore, it is expected that the combination of two activation methods might have a 
synergistic effect. This probable effect has been investigated in this study. 
Materials and Methods 
This study was conducted on colon carcinoma tumor in Balb/c mice. The tumors were induced by 
subcutaneous injection of CT26 cells.   Ultrasound and light irradiations were performed on tumors 24 hr after 
injection of liposomal Zn (II)-phthalocyanine. The treatment efficacy was evaluated using daily measurement 
of the tumor dimensions.  
Results 
Ten days post treatment, relative tumor volumes of all groups were significantly reduced in comparison with 
the main control group. The best response was observed when one of the two treatment methods had been 
applied. The longest doubling time of tumor was related to the treatment group namely photodynamic, 
sonodynamic and combination technique, while the shortest belonged to the control group. 
Conclusion 
This study showed that liposomal Zn phthalocyanine is both photosensitizer and sonosensitizer. Photodynamic 
and sonodynamic therapies can be efficient in retarding tumor growth rate. In this study, the combination of 
two methods didn’t show any improvement in therapeutic outcomes. It is predicted that latest results are 
related to the treatments sequence and could be optimized in the future. 
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Introduction  
Surgery, radiotherapy and chemotherapy are 
three appropriate methods used for the treatment 
of large invasive tumors (1). However, 
development of new techniques and/or 
improvement of detection techniques of 
malignant cells are crucial. In that case, there 
would be potent treatment methods for smaller 
tumors with less invasiveness.  Photodynamic 
therapy (PDT) is a treatment modality that 
combines a photosensitizing agent with a proper 
wavelength of light in order to selectively 
destroy cells. The interaction of photons with 
photosensitizers in the presence of oxygen 
molecules results in the formation of oxygen 
radicals and singlet oxygen that causes damage 
to the irradiated tissue; thus, the outcome will be 
necrosis and apoptosis (2).
 
Currently, PDT is routinely used in a number 
of countries such as Russia, England and Italy 
(3). However, only some studies have been 
reported on in vivo and in vitro application 
sonodynamic therapy in combination with the 
second or third generations of sensitizers (4-8). 
 
There are two important limitations on PDT; 
the first one is the side effects of the 
photosensitizers, and the second is the lack of 
penetration of visible light in tissues (9). 
Therefore, it seems logical to look for new 
modalities in order to decrease undesired side 
effects, and at the same time to increase the 
depth of treatment. On the other hand, there have 
also been reports confirming the activation of 
certain photosensitizers by ultrasound (10). 
Some studies on cell death mechanisms after 
ultrasonic activation of photosensitizers have 
been carried out. Based to these studies, 
cavitation is mainly responsible for producing 
free radicals and consequently cell death. This 
procedure is called sonodynamic therapy (SDT) 
and the dyes being used are known as 
sonosensitizer (11) 
Jin  et al (2000) evaluated the effect of 
combined sonodynamic and photodynamic 
therapies on squamous cell carcinoma of 
C3H/He mice in the presence of ATX-70 and 
PH-1126 as sensitizers. Based on their report, 
single treatment stopped tumor growth by 27-77 
percent, whereas combined treatment inhibited 
the tumor growth to 92-98 percent, and increased 
the animals’ survival from 77 to 95 days. 
Pathological examinations have indicated 2-3 
fold increase in the depth of tumor necrosis (12)  
Hachimine et al (2007) applied sonodynamic 
therapy after the administration of DCPH-P-Na 
(I) to Balb/c athymic nude mice. MKN-45 cells 
were subcutaneously injected into the back of 
nude mice and led to tumors with a diameter of 
approximately 5 mm. After 24 hr, ultrasound 
irradiation has been done for 10 min at 1 MHz, 
and two different intensities (1.0 or 2.0 W/cm
2) 
and a 50% duty cycle. The growth of the MKN-
45 tumors was significantly inhibited within 15 
days after the treatment in comparison with the 
control group (13). 
Local SDT combined with whole body PDT 
via photoflora as sensitizer is now being used at 
Opal clinic in Australia to treat breast and 
prostate carcinomas (14). Pharmacokinetic 
characteristics of zinc phthalocyanine (ZnPc) 
make this molecule a promising second 
generation phototherapeutic agent. Its quantum 
efficiency is relatively high to produce singlet 
oxygen, and its toxicity in the absence of light is 
low. Photoactivation of this dye in wavelength 
of 670 nm provides an extra feasibility in the 
treatment of relatively thick and deep tumors 
(15). Furthermore, Miloska et al (2005) have 
shown that ZnPc has sonosensitizing property 
(4), while preparing pharmaceutical formulations 
that enables ZnPc’s systemic administration is 
highly difficult. Due to their low water 
solubility, hydrophobic photosensitizers cannot 
directly be injected intravenously. As a result, 
several different strategies have been employed 
to prepare stable formulations of hydrophobic 
photosensitizers such as conjugation to water-
soluble polymers or encapsulation liposomes, 
gold and polymer nanoparticles (16). The current 
study has investigated photo and sono 
sensitizing properties of a liposomal ZnPc form. 
Because ultrasound would penetrate in soft 
tissues more than visible light (14), it was 
predicted that the combination of these 
treatments modalities could improve PDT 
efficacy in a certain dye dose. 
In this research, the combined effects of SDT 
and PDT on a colon carcinoma tumor model Effects of Combined SDT and PDT 
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have been evaluated using liposomal ZnPc. 
 
Materials and Methods 
Cell line and culture conditions 
CT26 cell line derived from a tumor colon 
carcinoma of a Balb/c mouse was grown in 
RPMI-1640 supplemented with 10% (v/v) fetal 
bovine serum (FBS), 50 units/ml penicillin and 
50 µg/ml streptomycin. Cell culture was 
performed at 37
  ○C in a 5% CO2 humidified 
incubator. They covered bottom of the flask as a 
monolayer after 2-3 days of the growth and 
proliferation of the cells. Exponentially growing 
cells were trypsinized using 0.05% trypsin-
EDTA. The cell survival rate and their number 
were determined by a hemocytometer using 
trypan blue.  
 
Tumor models 
Female and male Balb/c mice, aged 6 - 8 weeks 
weighing 20-22 g were purchased from Iranian 
Pasteur Institute. The mice were housed in an 
animal facility in Medical Physics Research 
Center at 23±2 °C, 65% moisture, and 12 hr 
darkness and brightness, alternatively. In order 
to create a tumor model, CT26 tumor cells 
(5×10
5  cells per mouse) were implanted 
subcutaneously in the right dorsum of animals. 
When the tumor volume reached 100±20 mm
3, 
the mice underwent the study. After tumor 
induction (nearly 30 days post injection), the 
tumor tissue was subjected to the pathological 
examinations and affirmed to be a tumor. 
 
Animals’ anesthesia 
The mice were anesthetized before the 
illumination or the exposure to ultrasound, via 
intraperitoneal injection of ketamine 
hydrochloride  (100  mg/kg),  and  chanazine        
(5 mg/kg) (17).  
 
Chemicals and preparation of liposomal ZnPc 
ZnPc was obtained from Sigma-Aldrich (97% 
dye content). In order to formulate the 
photosensitizer in a liposomal form, 300 mg of 
egg lecithin, 100 mg of cholesterol, 400 mg of 
glucose and the required amount of ZnPc 
powder were dissolved in 10 ml of pyridine. The 
solution was frozen through particular processes 
using dry ice and subsequently dried via freeze 
dryer (Labco Co-USA) during two consecutive 
stages of -40
  °C and -25 °C temperature 
designed for a period of 24 hr (18). Eventually, 
to prepare the final stable solution, 2 ml of 
distilled water was added and mixed completely 
by a vortex. Based on the spectroscopic results 
from the liposomal suspension supernatant, the 
encapsulation rate of ZnPc was determined to be 
more than 85% by this technique. Distribution 
and average of liposoms size were estimated as 
1- 6.5 µm and 1.6 µm, respectively (19).  
 
Light source 
An incoherent light source, as LUMACARE, 
equipped with a piece of fibers optic bundle and 
a band pass filter of 670±20 nm was utilized for 
illumining the tumors. Light homogeneity of the 
source was ±5%. Illumination intensity was 160 
mW/cm
2 and total exposed light was 300 J/cm
2 
(20). Illumination parameters were assessed by a 
photometer (CON-TROL-CURE IL1400; 
UVPROCESS, USA).  
 
Ultrasound generator system 
Irradiation of ultrasound was conducted with a 
215A ultrasound generator in continuous mode 
and frequency of 1.1 MHz with maximum 
intensity of 1 W/cm
2 for 10 min (21).
 Ultrasound 
probe was planar and surface area of the 
piezoelectric crystal was 7.0 cm
2. 
 
 
Experimental protocol  
As the tumor diameter reached about 5 mm, the 
animals were randomly divided into 8 groups 
each containing 10 mice (5 males and 5 females) 
(22). In the beginning of treatments, 1.46 µM/kg 
liposomal ZnPc was injected to four animal 
groups intraperitoneally (18, 23). After 24 hr (6), 
the tumors of one group were only irradiated by 
light. In the second group ultrasound was applied 
to the tumor as shown in Figure 1 (24),
 and the 
third group was treated by light followed by 
ultrasound. No irradiation was applied to the 
fourth group. In the other four groups of animals, 
normal saline was injected instead of 
photosensitizer and the same treatment regimes 
of the first four groups were applied.Maryam Bakhshizadeh et al 
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Figure1. The experimental set-up for ultrasound exposure to the animal tumor models. 
 
The treatments was followed up via daily 
measurement of tumor diameters- including small 
diameter (a), large diameter (b) and tumor 
thickness (c)- using a digital caliper with 0.01mm 
precision, and estimation of tumor volume (V) as 
V=  π/6 (a. b. c) (21). The measurements were 
continued until 120 days after treatment, which is 
the maximum survival time of animals. 
 
Treatments Efficacy Evaluation 
For each tumor, the first day of treatment was 
considered as day zero and relative tumor volumes 
in later days were accordingly normalized. On the 
basis of daily variations of the relative tumor 
volume, doubling time of each tumor was 
determined and the doubling time of the tumors 
was estimated in each group. 
The cumulative survival fraction was also 
assessed in various groups using Kaplan-Meier 
method. 
 
Statistical analysis  
All data were analyzed using SPSS 12 after 
performing normality test and selection of proper 
comparative tests. According to the normality 
test of Kolmogorov-Smirnov, the data 
distribution was not normal. Consequently, the 
Mann-Whitney U test was used to compare 
relative tumor volume with a confidence level of 
95%. Moreover, after calculating the cumulative 
survival fraction of animals via Kaplan-Meier 
method, log rank test was applied to compare 
between groups. Doubling time of tumors was 
also compared in different groups using T-Test.  
 
Results 
Treatment results of different groups were 
evaluated from different viewpoints including 
comparison of relative tumor volume in the post 
treatment first day, function of relative tumor 
volume versus day and doubling time of the 
tumor volume. Relative tumor volume variations 
are presented in Figure 2. In all groups, the 
growth of the CT26 tumor was significantly 
inhibited within 10 days after the treatment in 
comparison with the control group (P< 0.001). 
The groups received PDT or SDT showed 
significant differences in comparison with the 
groups receiving only dye, light, or ultrasound 
(P< 0.012). Furthermore, significant difference 
in the relative tumor volume was observed 
between the groups receiving combined 
treatment and PDT or SDT (P< 0.003). 
Considering variations of the relative tumor 
volume and correlation of various mathematical 
functions fitted into the data obtained from 
different groups, the most suitable equation with 
the best regression corresponding to 
experimental data was evaluated for each group. 
These functions and their regressions (R
2) are 
shown in Table 2.  
As it can be seen, mean of tumor volume 
changes in all groups followed an exponential 
function except for groups of photodynamic, 
sonodynamic and combined treatments which 
were fitted into a third power function. 
Tumors doubling time of different groups is 
shown in Figure 3. The longest doubling times 
were observed in photodynamic, sonodynamic 
and combined treatment groups, respectively. 
The shortest doubling time of tumors was 
observed in the control group (3.36 days). 
Cumulative survival fractions for different 
groups are recorded in Figure 4. Effects of Combined SDT and PDT 
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Figure 2. Relative variations of tumor volume in different groups for the first 10 days post treatment. The data show the 
mean of 10 tumor volume measurements in each group. 
 
Table 2. Correlation of various mathematical functions with relative tumor volume variations in different groups and the 
best fitted mathematical function with the R
2-value corresponding to empirical data for each group (V0 indicates the 
relative tumor volume and t shows the days after treatment). 
Group  The best fitted mathematical function  R
2 
control  vr   =e
( 0.0787t)  0.881 
Receiving light  vr   =e
(0.0926 t)  0.904 
Receiving ultrasound  vr   =e
(0.0793 t)  0.921 
Receiving liposomal ZnPc  vr   =e
(0.0919 t)  0.909 
Receiving light and ultrasound  vr   =e
(0.0716 t)  0.857 
Photodynamic therapy  vr   = - 0.377 t+ 0.43 t
2+ (0.25×10
-4) t
3  0.910 
Sonodynamic therapy  vr   = - 0.367 t+ 0.0388 t
2+ (4×10
-4) t
3  0.873 
Combined treatment  vr   = - 0.0856 t+ 0.0655 t
2- (3×10
-4) t
3  0.845 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Mean of tumors doubling time (± standard deviation) in various groups (each group comprising 10 mice) 
    Maryam Bakhshizadeh et al 
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Figure 4. Variations of cumulative survival fraction in different treatment groups versus day based on Kaplan-Meier 
calculations (each group includes 10 mice). 
 
Animals’ survival didn’t show significant 
difference between group receiving SDT and the 
groups receiving only ultrasound or dye. The 
difference of animals’ survival between PDT and 
the groups receiving only light or dye was not 
significant either. While in combined treatment, 
there is a significant difference in comparison 
with the group subjected to SDT (P= 0.03) was 
observed.  
 
Discussion 
PDT and SDT have been frequently applied to 
treat small tumors using different dyes as a 
photosensitizer such as protoporphyrin IX or 
sonosensitizer, e.g. ATX-70. Recently, metal 
phthalocyanines have been utilized by many 
researchers as second generation 
photosensitizers. The study of Miloska et al 
(2005) indicated ultrasonic sensitization of ZnPc 
(4). Considering photo and sono sensitivities and 
hydrophobic property of ZnPc, the proposing of 
a proper formulation without canceling its 
optical and sonic specifications is useful. There 
are several approaches to prepare stable 
formulations of hydrophobic photosensitizers 
such as conjugation to water-soluble polymers, 
gold and polymer nanoparticles, and 
encapsulation liposomes (16). In current research 
photo and sono sensitizing properties of a 
liposomal ZnPc form have been examined. 
Furthermore, PDT and SDT modalities were 
combined to improve PDT efficacy via a single 
dose of liposomal dye. Thus far, there has not 
been reported a similar research considering all 
parameters of our study to evaluate photo and 
sono sensitivities of ZnPc.  
Based on our results, the best response to the 
treatment was observed in groups subjected to 
photodynamic or sonodynamic therapy. Also 
under these circumstances, relative decrease in 
tumor volume was more than combined 
treatment. Regarding increased animals’ 
cumulative survival fraction in combined 
treatment, it can be  introduced as an effective 
mechanism to prolong survival of the animals in 
comparison with groups receiving photodynamic 
or sonodynamic therapies alone, and it can be 
inferred that attention to the tumor size 
variations is not sufficient to judge the efficacy 
of photodynamic and sonodynamic therapies.   
Therefore, if the data concerning two 
parameters of tumor volume variations and 
animals’ cumulative survival fraction are 
compared with reference to daily variations of 
the tumor volume after treatment, efficacy in 
combined treatment would be lower than PDT or 
SDT, while animals’ survival in combined 
treatment has been recorded higher than 
individual treatments.  
On the other hand, soft tissue can encounter at Effects of Combined SDT and PDT 
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least one of these events after ultrasound 
exposure: permeability in cell membrane, and 
sonodynamic activation (25). In the present 
study, utilization of the second procedure was 
our goal. However, induced permeability in cell 
membrane is more feasible at lower frequencies 
of ultrasound (26), nevertheless, after interacting 
of mechanical strokes with cell membrane, 
enhancement in cell permeability and subsequent 
leakage of ZnPc molecules is not impossible. 
Because SDT was administered before PDT, an 
assumption is therefore reinforced in relation to 
increased permeability of cell membrane and 
excretion of some ZnPc molecules from the 
tumor cells. 
Considering significant loss of animals’ 
survival in the group receiving liposomal ZnPc 
in comparison with control group, drug toxicity 
in intraperitoneal injection can be proposed; 
however, regarding significant increase in 
animals’ survival in the group subjected to 
combined treatment in comparison with the 
groups receiving only one treatment, it seems 
that effective combined treatment was due to 
drug toxicity. In other words, if the group 
receiving drug is considered as a sham group, 
after combined treatment and activation of ZnPc 
by light and ultrasound, enhancement in 
cumulative survival would be greater than its 
loss resulting from drug toxicity.  
 
Conclusion 
Treatment response in groups subjected to 
photodynamic or sonodynamic therapy confirmed 
photo and sono activations of liposomal ZnPc. It 
can be inferred that photodynamic and 
sonodynamic therapies could be effective in 
slowing down the tumor growth process, but it is 
evident that the tumor growth would not stop 
while just one treatment session is applied.  
Since in the combinational treatment, 24 hr 
after injecting of liposomal ZnPc, the tumors had 
been subjected to the irradiation of ultrasound 
and light respectively and leakage of sensitizer 
molecules from tumor cells after ultrasound 
exposure is predicted, it is expected that reverse 
treatment sequence can provide better response.  
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